REG - MyCelx Tech. Corp. MyCelx Tech. Cp-MYXR - Trading Update

Mycelx TechnologiesAnnouncement

20/01/2026 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260120:nRST4533Pa&default-theme=true

RNS Number : 4533P  MyCelx Technologies Corporation  20 January 2026

The information contained within this Announcement is deemed by MYCELX
Technologies Corporation to constitute inside information as stipulated under
the Market Abuse Regulation (EU) No. 596/2014 as it forms part
of UK domestic law by virtue of the European Union (Withdrawal) Act 2018
("MAR").

 

20 January 2026

 

MYCELX Technologies Corporation

("MYCELX" or the "Company")

 

MYCELX Achieves Profitability in 2025 Outperforming Market Expectations

 

MYCELX Technologies Corporation (AIM: MYX), the clean water and clean air
technology company, is pleased to provide a year-end financial update,
reporting expected profitability that significantly exceeds market
expectations, along with an update on the Company's strategy for its core
markets.

 

The Company expects FY2025 year-end revenue of c.a. $11.7 million, a 140%
improvement over FY2024, although slightly less than market expectations of
$12.5 million.

 

While EBITDA and profit before tax ('PBT') remain subject to year-end closing
procedures, the Company expects EBITDA to be in the region of $680,000, a 131%
improvement over FY2024, which includes a gain of $160,000 from the sale of
its Saudi Arabia operations, and $520,000 without the gain, compared to market
expectations of an EBITDA loss of $200,000.

 

PBT is expected to be in the region of $360,000, including the gain. This
materially exceeds the market expectations of a PBT loss of $600,000.
Excluding this gain, PBT is c.a. $200,000.

 

This outperformance reflects strict cost discipline, operating leverage, and
an increased contribution from higher-margin revenue.

 

Cash and cash equivalents at year-end are $860,000, including $50,000
restricted cash. The Company also expects to collect approximately $4 million
in cash during Q1 2026.

 

Current Trading and Outlook

 

We enter 2026 with a stronger earnings profile, a streamlined organization,
and increasing commercial momentum across our core markets in the U.S. and
internationally. The actions taken in 2024 and executed in 2025 have
repositioned the Company for faster customer adoption, multiple project wins,
and improved cash generation. Our relationships in the Middle East remain
strong, and traction in the U.S. is accelerating following successful trials
and deployments with both existing and new customers. We remain disciplined in
capital allocation and margin expansion as we scale the business and focus on
delivering sustainable, long-term value.

 

While the Company is optimistic about the prospects for 2026 and beyond, at
this point in the year the company is maintaining current year guidance and
will update the market in due course when there is greater visibility on a
number of major contracts.

 

Strategic Update

 

The Company's core markets have been refined to concentrate on Produced Water,
PFAS and Water Services (industrial water treatment) as the key focus markets.
Produced Water treatment remains the primary focus. PFAS Remediation is slowly
evolving into a major market, and the Company is engaged in specific verticals
within PFAS that currently have budget to spend. In the case of Water
Services, the Company has been selling legacy products into niche applications
that add high margin revenue and growing that incremental business will be
achieved by expanding roles and repositioning current personnel.

 

The Board was pleased to elevate Matthew Goysich, Director of Engineering, to
Executive Vice President and Jim Weidler, to Executive Vice President of
Business Development. Both executives have joined the Executive Management
team and will attend Board Meetings to provide their insight on our core
markets and commercial and strategic plan progress. We congratulate both
Matthew and Jim on their well-earned promotions.

 

The Company will make new hires this year in Engineering and Business
Development in Q1. The engineering hire will allow Matthew to spend more time
with key clients, closing sales and influencing tactics and strategy. Driving
our business in the Permian Basin requires an experienced sales professional
with relationships and water experience. This initiative and overall sales and
marketing reporting and activity will be managed by Jim Weidler.

 

Connie Mixon, CEO, commented:

 

"Achieving profitability represents an important inflection point for MYCELX.
Our reputation for delivering advanced technology that economically provides
better performance is increasingly recognized among key market players
globally. We are excited to continue to vigorously execute our successful
strategy to win more business and strengthen our financial profile as we
create long-term value for all stakeholders".

 

 

For further information, please contact:

 

 MYCELX Technologies Corporation

 Connie Mixon, CEO                                                      Tel: +1 888 306 6843

 Kim Slayton, CFO

 Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker)

 Giles Balleny / Callum Davidson / Elysia Bough (Corporate Finance)     Tel: +44 20 7220 0500

 Harriet Ward (Corporate Broking)

 Jasper Berry / Michael Johnson (Sales)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  TSTAKCBBDBKDKDD



            Copyright 2019 Regulatory News Service, all rights reserved